Stocktoria
Nuvalent, Inc. NUVL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-07-29
Nuvalent, Inc. statistics & valuation
Market cap$9.8B
P / B7.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -30.1% | -22.8% | -17.2% | -17.0% | -15.8% |
| Return on equity | -34.1% | -24.4% | -18.0% | -17.7% | -16.3% |
| Current ratio | 15.27 | 20.96 | 22.83 | 24.54 | 33.07 |
Source: SEC EDGAR filings · CIK 0001861560 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.